Skip to main content
Shukra Pharmaceuticals Limited logo

Shukra Pharmaceuticals Limited — Investor Relations & Filings

Ticker · 524632 ISIN · INE551C01044 LEI · 984500650D08AFF75E91 BSE.NS Manufacturing
Filings indexed 1 across all filing types
Latest filing 2026-05-09 Regulatory Filings
Country IN India
Listing BSE.NS 524632

About Shukra Pharmaceuticals Limited

https://shukrapharmaceuticals.com/

Shukra Pharmaceuticals Limited specializes in the development, manufacturing, and marketing of a broad spectrum of pharmaceutical formulations. The company’s product portfolio encompasses various dosage forms, including tablets, capsules, and injections, covering therapeutic areas such as antibiotics, anti-infectives, analgesics, and anti-inflammatory agents. Utilizing advanced manufacturing facilities that adhere to stringent quality standards, the organization focuses on the production of generic medicines and provides contract manufacturing services. The company maintains a commitment to operational excellence through rigorous quality control processes and compliance with Good Manufacturing Practices (GMP). Its strategic focus involves expanding its market presence by delivering cost-effective healthcare solutions and high-quality medicinal products to a global clientele.

Recent filings

Filing Released Lang Actions
Newspaper publication of Standalone Audit Financial Results for Fourth Quarter and Financial Year ended on 31st March 2026
Regulatory Filings
2026-05-09 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.